Randomized phase II adjuvant trial of dose-dense docetaxel before or after doxorubicin plus cyclophosphamide in axillary node-positive breast cancer.

Puhalla, S., Mrozek, E., Young, D., Ottman, S., McVey, A., Kendra, K., Merriman, N.J., Knapp, M., Patel, T., Thompson, M.E., Maher, J.F., Moore, T.D., Shapiro, C.L.; J Clin Oncol. 2008 Apr 1.

Taxanes and capecitabine in combination: rationale and clinical results.

Maher, J.F., Villalona-Calero, M.A.; Clin Breast Cancer. 2002 Jan.

Randomized phase II study of gemcitabine plus cisplatin or carboplatin [corrected], with or without cetuximab, as first-line therapy for patients with advanced or metastatic non small-cell lung cancer.

Butts, C. A., Bodkin, D., Middleman, E. L., Englund, C. W., Ellison, D., Alam, Y., Kreisman, H., Graze, P., Maher, J., Ross, H. J., Ellis, P. M., McNulty, W., Kaplan, ...; J Clin Oncol. 2007 Dec 20.